BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/12/2023 8:10:41 AM | Browse: 215 | Download: 708
 |
Received |
|
2022-12-04 14:34 |
|
Peer-Review Started |
|
2022-12-04 14:35 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-12-26 03:18 |
|
Revised |
|
2023-01-09 08:46 |
|
Second Decision |
|
2023-03-08 03:04 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-03-08 18:07 |
|
Articles in Press |
|
2023-03-08 18:07 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-04-06 04:39 |
|
Publish the Manuscript Online |
|
2023-04-12 08:10 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Lipid metabolism of hepatocellular carcinoma impacts targeted therapy and immunotherapy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Xiao-Chen Feng, Fu-Chen Liu, Wu-Yu Chen, Jin Du and Hui Liu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81970453 |
| National Natural Science Foundation of China |
82270634 |
| Shanghai Science and Technology Innovation Action Plan Project |
20XD1405100 |
|
| Corresponding Author |
Hui Liu, MD, PhD, Chief Doctor, Professor, The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, No. 225 Changhai Road, Shanghai 200082, China. liuhuigg@hotmail.com |
| Key Words |
Hepatocellular carcinoma; Lipid metabolism; Targeted therapy; Immunotherapy; Drug resistance; Therapeutic efficacy |
| Core Tip |
This review systematically summarizes the aberrant changes of lipid metabolism in hepatocellular carcinoma (HCC), and for the first time expounds the impact of lipid metabolism on HCC targeted therapy and immunotherapy. It vividly displayed the changes of lipid metabolism in HCC and the targets of some reagents by drawing figures, and summarized the impact of lipid metabolism related reagents on HCC targeted therapy and immunotherapy through table. |
| Publish Date |
2023-04-12 08:10 |
| Citation |
Feng XC, Liu FC, Chen WY, Du J, Liu H. Lipid metabolism of hepatocellular carcinoma impacts targeted therapy and immunotherapy. World J Gastrointest Oncol 2023; 15(4): 617-631 |
| URL |
https://www.wjgnet.com/1948-5204/full/v15/i4/617.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v15.i4.617 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
